文献
J-GLOBAL ID:201702231421283178
整理番号:17A1824909
Secukinumabは中等度から重度の尋常性乾癬患者におけるウステキヌマブより日常活動と個人の関係における大持続的改善を示す:CLEAR研究からの52週結果【Powered by NICT】
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study
著者 (12件):
Blauvelt A.
(Oregon Medical Research Center, Portland, OR, USA)
,
Reich K.
(Dermatologikum Hamburg and SCIderm GmbH, Hamburg, Germany)
,
Mehlis S.
(NorthShore University Health System, Skokie, IL, USA)
,
Vanaclocha F.
(Dermatology Department, Hospital Universitario, Madrid, Spain)
,
Sofen H.
(Department of Medicine (Dermatology) UCLA, Los Angeles, CA, USA)
,
Abramovits W.
(Baylor University Medical Center, Dallas, TX, USA)
,
Zhao Y.
(Formerly with Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA)
,
Gilloteau I.
(Novartis Pharma AG, Basel, Switzerland)
,
Davenport E.
(RTI Health Solutions, Research Triangle Park, NC, USA)
,
Williams N.
(RTI Health Solutions, Research Triangle Park, NC, USA)
,
Guana A.
(Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA)
,
Tyring S.
(University of Texas Health Science Center for Clinical Studies, Houston, TX, USA)
資料名:
Journal of the European Academy of Dermatology & Venereology
(Journal of the European Academy of Dermatology & Venereology)
巻:
31
号:
10
ページ:
1693-1699
発行年:
2017年
JST資料番号:
W2666A
ISSN:
0926-9959
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)